2022 | Q2 | US | US start-up sends tiny robots on voyage into human brains

https://bigkingfisher.substack.com/p/2022-q2-us-us-start-up-sends-tiny
https://www.scmp.com/news/world/united-states-canada/article/3174184/us-start-sends-tiny-robots-voyage-human-brains
#Agenda2O22 | @Agenda2O22
https://t.me/JoinTheWhiteRose

2022 | Q2 | US | US START-UP SENDS TINY ROBOTS ON VOYAGE INTO HUMAN BRAINS
chute.ROcKS/q1KJq8lZkFHR

The injectable micro machines from Bionaut Labs can be carefully guided inside the skull through the use of magnets. Inventors hope to use the robots to target tumours in ‘surgical strikes’, or pierce fluid-filled cysts within the brain.

Agence France-Presse Published: 7:35am, 14 Apr, 2022

Bionaut Labs plans its first clinical trials on humans in two years for its tiny injectable robots, which can be carefully guided through the brain using magnets. Magnetic coils placed outside the patient's skull are linked up to a computer that can remotely and delicately manoeuvre the micro-robot into the affected part of the brain. Inventors hope to use the robot to pierce fluid-filled cysts within the brain when clinical trials begin in two years. If successful, the process could be used to treat Dandy-Walker Syndrome, a rare brain malformation affecting children. Bionaut Labs has already tested its robots on large animals such as sheep and pigs.

The robots can inject anticancer drugs directly into the brain in a "surgical strike" They can also take measurements and collect tissue samples while inside the brain. Bionaut Labs hopes to use its technology to treat other conditions affecting the brain including Parkinson's, epilepsy or strokes. The US Food and Drug Administration (FDA) last year granted Bionaut Labs approvals that pave the way for clinical trials to treat Dandy-Walker Syndrome, as well as malignant gliomas – cancerous brain tumours often considered to be inoperable.

| Edward DOWD
"In fact, if you look at the stock charts of those funeral homes, they didn't do much in 2020, but they were growth stocks last year and they accelerated in the 2nd half of last year. One of them was up 106% and another was up 68%. Those are growth stocks. We should not be seeing funeral home companies as growth stocks.

MAKING THE CONNECTION ?